136 related articles for article (PubMed ID: 20430486)
1. [Skin pigmentation in a patient with systemic lupus erythematosus].
Jallouli M; Leroux G; Halabi-Tawil M; Morel N; Francès C; Piette JC; Amoura Z; Costedoat-Chalumeau N
Rev Med Interne; 2010 Aug; 31(8):566-7. PubMed ID: 20430486
[No Abstract] [Full Text] [Related]
2. Longitudinal melanonychia and subungual hemorrhage in a patient with systemic lupus erythematosus treated with hydroxychloroquine.
Zhang S; Liu X; Cai L; Zhang J; Zhou C
Lupus; 2019 Jan; 28(1):129-132. PubMed ID: 30428763
[TBL] [Abstract][Full Text] [Related]
3. Generalized skin hyperpigmentation and longitudinal melanonychia secondary to treatment with hydroxychloroquine in systemic lupus erythematosus.
Sifuentes Giraldo WA; Grandal Platero M; de la Puente Bujidos C; Gámir Gámir ML
Reumatol Clin; 2013; 9(6):381-2. PubMed ID: 23481508
[No Abstract] [Full Text] [Related]
4. Hydroxychloroquine-induced pigmentation in patients with systemic lupus erythematosus: a case-control study.
Jallouli M; Francès C; Piette JC; Huong du LT; Moguelet P; Factor C; Zahr N; Miyara M; Saadoun D; Mathian A; Haroche J; De Gennes C; Leroux G; Chapelon C; Wechsler B; Cacoub P; Amoura Z; Costedoat-Chalumeau N;
JAMA Dermatol; 2013 Aug; 149(8):935-40. PubMed ID: 23824340
[TBL] [Abstract][Full Text] [Related]
5. Hydroxychloroquine-induced hyperpigmentation.
Tracy CL; Blakey B; Parker G; Roebuck J
J Clin Rheumatol; 2013 Aug; 19(5):292. PubMed ID: 23884186
[No Abstract] [Full Text] [Related]
6. Hydroxychloroquine-induced hyperpigmentation in systemic diseases: prevalence, clinical features and risk factors: a cross-sectional study of 41 cases.
Bahloul E; Jallouli M; Garbaa S; Marzouk S; Masmoudi A; Turki H; Bahloul Z
Lupus; 2017 Oct; 26(12):1304-1308. PubMed ID: 28355984
[TBL] [Abstract][Full Text] [Related]
7. Hydroxycholoroquine-induced hyperpigmentation.
Mir A; Boyd KP; Meehan SA; McLellan B
Dermatol Online J; 2013 Dec; 19(12):20723. PubMed ID: 24365014
[TBL] [Abstract][Full Text] [Related]
8. Woman in grey: hydroxychloroquine-induced hyperpigmentation.
Ivo R; Lopes CA; Reis R
BMJ Case Rep; 2018 Nov; 11(1):. PubMed ID: 30567137
[No Abstract] [Full Text] [Related]
9. Hydroxychloroquine-related hyperpigmentation.
Muller R; Jarrot PA; Kaplanski G
Rheumatology (Oxford); 2022 Feb; 61(2):873. PubMed ID: 33871581
[No Abstract] [Full Text] [Related]
10. Hydroxychloroquine-induced pigmentation in two patients with systemic lupus erythematosus.
Reynaert S; Setterfield J; Black MM
J Eur Acad Dermatol Venereol; 2006 Apr; 20(4):487-8. PubMed ID: 16643169
[No Abstract] [Full Text] [Related]
11. Hydroxychloroquine-Associated Hyperpigmentation in Chilblain Lupus Erythematosus.
Horino T; Ichii O; Terada Y
J Clin Rheumatol; 2020 Sep; 26(6):e192. PubMed ID: 31116124
[No Abstract] [Full Text] [Related]
12. Porphyria precipitated by hydroxychloroquine treatment of systemic lupus erythematosus.
Baler GR
Cutis; 1976 Jan; 17(1):96-8. PubMed ID: 1017229
[TBL] [Abstract][Full Text] [Related]
13. Oral manifestations associated with antimalarial therapy in patients with systemic lupus erythematosus.
Chacón-Dulcey V; López-Labady J; Villarroel-Dorrego M; Frías J; Tirado W; González N; Pérez Alfonzo R
Lupus; 2020 Jun; 29(7):761-766. PubMed ID: 32362181
[TBL] [Abstract][Full Text] [Related]
14. Retinal toxicity found in a patient with systemic lupus erythematosus prior to 5 years of treatment with hydroxychloroquine.
Chiang E; Jampol LM; Fawzi AA
Rheumatology (Oxford); 2014 Nov; 53(11):2001. PubMed ID: 25172940
[No Abstract] [Full Text] [Related]
15. [Association between myasthenia gravis and systemic lupus erythematosus: is it safe to use hydroxychloroquine?].
Fernandez-Sanz A; Bucar-Barjud M; Ruiz-Serrano J; Saez-Comet L; Capablo-Liesa JL
Rev Neurol; 2017 May; 64(9):431-432. PubMed ID: 28444686
[TBL] [Abstract][Full Text] [Related]
16. Early hydroxychloroquine macular toxicity.
Warner AE
Arthritis Rheum; 2001 Aug; 44(8):1959-61. PubMed ID: 11508449
[TBL] [Abstract][Full Text] [Related]
17. Lupus profundus in children: treatment with hydroxychloroquine.
Fox JN; Klapman MH; Rowe L
J Am Acad Dermatol; 1987 Apr; 16(4):839-44. PubMed ID: 3571546
[TBL] [Abstract][Full Text] [Related]
18. Hyperpigmentation of the skin due to hydroxychloroquine.
Rood MJ; Vermeer MH; Huizinga TW
Scand J Rheumatol; 2008; 37(2):158. PubMed ID: 18415776
[No Abstract] [Full Text] [Related]
19. Hydroxychloroquine-induced hyperpigmentation of the skin.
Sawalha AH
J Rheumatol; 2015 Jan; 42(1):135-6. PubMed ID: 25554808
[No Abstract] [Full Text] [Related]
20. Hydroxychloroquine-induced hyperpigmentation: the staining pattern.
Puri PK; Lountzis NI; Tyler W; Ferringer T
J Cutan Pathol; 2008 Dec; 35(12):1134-7. PubMed ID: 18727667
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
